Marina Buys Novosom Delivery Technology for $5M in Stock
Marina Biotech, formerly MDRNA, said this week that it has acquired certain drug-delivery intellectual property from Novosom for roughly $5 million in stock.
Marina Biotech, formerly MDRNA, said this week that it has acquired certain drug-delivery intellectual property from Novosom for roughly $5 million in stock.